In Brief
Sewart and Hauf show that fission yeast Mad3 requires a conserved ABBA-KEN-ABBA motif in its C terminus for binding to a second Cdc20 molecule, MCC-APC/C association, and mitotic checkpoint activity-showing conservation across eukaryotes. Unlike in human cells, Apc15 is required for MCC-APC/C interaction and checkpoint activity. ) through additional binding sequences in Mad3/BubR1 [4] [5] [6] . Here, we dissect the different functionality of these sites in vivo. We show in fission yeast that, at low Cdc20 concentrations, Cdc20 M binding is sufficient for checkpoint activity and Cdc20
A binding becomes dispensable. Cdc20 A binding is mediated by the conserved Mad3 ABBA-KEN2-ABBA motif [7, 8] , which we find additionally required for binding of the MCC to the APC/C and for MCC disassembly. Strikingly, deletion of the APC/C subunit Apc15 mimics mutations in this motif, revealing a shared function. This function of Apc15 may be masked in human cells by independent mediators of MCC-APC/C binding. Our data provide important in vivo support for the recent structurebased models and functionally dissect three elements of Cdc20 inhibition: (1) sequestration of Cdc20 in the core MCC, sufficient at low Cdc20 concentrations; (2) inhibition of a second Cdc20 through the Mad3 C terminus, independent of Mad2 binding to this Cdc20 molecule; and (3) occupancy of the APC/C with full MCC, where Mad3 and Apc15 are involved.
RESULTS AND DISCUSSION
Several Conserved Motifs in the Mad3 C Terminus Are Required for Checkpoint Activity Recent high-resolution structures have revealed the arrangement of the core mitotic checkpoint complex (MCC) [9] and of the entire MCC-anaphase-promoting complex/cyclosome (APC/C) complex [4, 6] ( Figures 1A and 1D ). Mad3/BubR1 plays a key role as it contacts both Cdc20 molecules in the MCC-APC/C complex through multiple motifs that resemble APC/C degradation signals [10] . Despite the high-resolution views, the functional analysis of these motifs in vivo is lagging behind. Fission yeast (S. pombe) is ideal to study this, because its Mad3/BubR1 gene has, over evolutionary timescales, been trimmed down to a minimal Cdc20-inhibitory fragment [7, 8] ( Figures 1A and S1A ). S. pombe Mad3 shares with most other eukaryotes the N-terminal KEN (lysine-glutamate-asparagine) motif (KEN1), which is required for core MCC formation and checkpoint activity [11] [12] [13] . Following the tetratricopeptide (TPR) repeats is a D-boxmimicking motif [9] and another KEN motif (KEN2), both of which assist binding to Cdc20 A and checkpoint activity in human cells [5, 12, 14] . By motif search and visual inspection of a sequence alignment of this region, we additionally identified two candidate ABBA motifs [15] that flank KEN2 ( Figure 1A ). Recent phylogenetic analysis found that this ABBA-KEN2-ABBA arrangement is highly conserved across eukaryotes [7, 8] To assess the relative importance of these Mad3 motifs for the mitotic checkpoint, we mutated each individually and replaced the endogenous S. pombe mad3 + gene with the respective mutated gene. Wild-type and mutant genes were C-terminally tagged with GFP, and expression resulted in similar protein concentrations ( Figure S1F ). We tested checkpoint activity by using a cold-sensitive tubulin mutation (nda3-KM311) to abolish microtubule formation and measured the time that single cells delayed in mitosis by following localization of Plo1-mCherry to spindle pole bodies [16] . To analyze MCC formation, we obtained mitotic cells by synchronization of cultures at the G2/M transition and release into mitosis in the presence of a microtubule drug, and immunoprecipitated Mad3-GFP. As expected, mutation of Mad3-KEN1 abolished checkpoint activity and formation of the core MCC ( Figures 1B and 1C ) [13] . In contrast, but also in agreement with previous results, mutation of KEN2 strongly diminished checkpoint activity but without impairing core MCC formation ( Figures 1B and 1C ) [13] . Mutation of the D-box-mimicking motif led to a partial checkpoint defect ( Figures 1B and S1G ). Mutation of ABBA1 strongly diminished checkpoint activity, and mutation of ABBA2 led to a weaker checkpoint defect ( Figure 1B) , as was recently observed in human cells [6] [7] [8] . Truncating the Mad3 C terminus containing ABBA2 as well as adjacent conserved sequences (mad3-DCterm) largely abrogated checkpoint activity ( Figure 1B ). Similar to the KEN2 mutation, this truncation did not abolish core MCC formation ( Figure 1C ). Hence, Mad3-KEN2, and motifs surrounding it, are required for checkpoint activity without being required for core MCC formation. 
(legend continued on next page)
In many eukaryotes, Bub3 is an additional subunit of the MCC [1, 2] . Bub3 binds to the GLEBS (or B3BD) motif in Mad3/BubR1, downstream of ABBA2 ( Figure 1A ). In several fission yeast species, including S. pombe, Mad3 ends after the ABBA2 but before the GLEBS motif ( Figure S1A ) [7, 8] , making it unlikely that S. pombe Bub3 directly binds to Mad3. Nevertheless, immunoprecipitation of S. pombe Mad3 co-precipitates Bub3 and vice versa [17] (Figures S1C-S1E). We found that this interaction is most likely indirect, because it is abolished by deletion of bub1 + but largely unaffected by truncation of the Mad3 C terminus (Figures S1D and S1E). We therefore presume that Bub3 is not part of the S. pombe MCC. Bub1 is a plausible mediator of the Bub3-Mad3 interaction, because it forms a complex with Bub3 [18] , and human Bub1 interacts directly with Mad3/ BubR1 [19] .
Conserved Motifs in the Mad3 C Terminus Allow Binding of a Second Cdc20 Slp1 Molecule to the MCC While our analysis of S. pombe Mad3 mutants was ongoing, the structure of the human APC/C-MCC complex was solved at high resolution [4] . This revealed that the stretch of Mad3/ BubR1 C-terminal of the TPR domain wraps around Cdc20
A using the D-box mimic, ABBA1, and KEN2 motif and then binds back to Cdc20 M , most likely through ABBA2, forming a lariat ( Figure 1D ). Consistently, mutations in the human BubR1 D-box mimic and KEN2 motif impair binding to Cdc20
A [5] . Cdc20 from mitotic cells co-purified untagged Slp1 Cdc20 ( Figure 1E , lane 2). When we prevented core MCC formation through deletion of mad2 or the Mad3-KEN1AAA mutation, co-purification was abolished ( Figure 1E , lanes 4 and 5). Hence, tagged and untagged Slp1 Cdc20 do not directly bind to each other outside the MCC, and untagged Slp1 Cdc20 is not precipitated by the GFP antibody. Consistent with results from human cells [5] , binding of additional, untagged Slp1 Cdc20 did not require its Mad2-interaction motif in the N terminus (slp1-mr63 mutant [20] ; Figure 1E , lane 3). In contrast, mutation of Mad3-KEN2 as well as truncation of Mad3 (Mad3-DCterm) abolished the interaction ( Figure 1E , lanes 6 and 7). Hence, the interaction of the core MCC with additional Cdc20 (Cdc20 A ) through the Mad3 C-terminal sequence motifs is conserved across eukaryotes ( Figure 1D ). The lariat mode of binding provides a rationale how the Mad3-C terminus, containing ABBA2, can be involved in Cdc20 A binding, although its direct contact is likely to Cdc20 M .
A Cdc20 Slp1 Mutant that Is Unable to Bind Mad2 Can Be Prevented from Initiating Anaphase
In several species, the expression of Cdc20 that is unable to bind Mad2 (like Slp1 Cdc20 -mr63) leads to a checkpoint defect [20] [21] [22] . We reasoned that such Mad2-binding-deficient Cdc20 should still be subject to checkpoint control through the Mad3 C terminus, as long as core MCC can be formed. We therefore co-expressed wild-type Slp1
Cdc20 (able to integrate into the core MCC) and the Mad2-binding-deficient mutant Slp1 Cdc20 -mr63. Slp1 Cdc20 -mr63 alone leads to checkpoint failure ( Figure S1H ) [20] . The checkpoint remained non-functional when equal levels of wild-type and mutant Slp1 Cdc20 -mr63 were expressed ( Figure 1F ). However, when Slp1 Cdc20 -mr63 abundance was reduced by expressing the gene from the rad21 + (cohesin) promoter [16] , the checkpoint could be partially restored as long as wild-type Slp1
Cdc20 was present (Figures 1F and S1H). As expected, Slp1
Cdc20 -mr63 bound to the MCC ( Figure 1G ). To make APC/C activation entirely dependent on Slp1 Cdc20 -mr63, we mutated the C-box in the Slp1 Cdc20 copy that was Mad2-binding proficient. The C-box is essential for Cdc20 to bind and activate the APC/C [23, 24] but is not required for the core MCC to bind the APC/C [25] . The checkpoint rescue was enhanced when the tagged, Mad2-binding-competent Slp1
Cdc20 carried a mutation in the C-box ( Figure 1F ). In this situation, APC/C activation solely relies on Slp1 Cdc20 -mr63. In the presence of checkpoint signaling, Slp1 Cdc20 -mr63 activity was efficiently blocked despite lacking the Mad2-binding sequences ( Figure 1F ). Mutation of Mad3-KEN2 abolished binding of Slp1 Cdc20 -mr63 to the core MCC and led to a checkpoint defect ( Figures 1F and 1G) . Similarly, truncation of the Mad3 C terminus led to a checkpoint defect ( Figure 1F ). Hence, Slp1 Cdc20 -mr63, which is unable to bind Mad2, can be inhibited through the Mad3 C terminus as long as core MCC formation is initiated by Mad2-binding-competent Slp1 Although both Mad3-KEN boxes are required for mitotic checkpoint activity, mutation of KEN1 abolishes checkpoint activity more than mutation of KEN2 (Figure 2A , inset) [8, 14, 26] . Congruently, Mad3-KEN1 is needed for interaction of both Cdc20 M and Cdc20
A with the MCC, whereas Mad3-KEN2 is only needed for interaction of Cdc20 A ( Figures 1C and 1E ) [5] . Because Cdc20 M can be tightly captured in the core MCC, we reasoned that such sequestration could be sufficient for checkpoint activity at low Cdc20 concentrations. We therefore lowered Slp1 Cdc20 concentration by expressing the gene from the rad21 + promoter [16] ( Figure S2A ). Checkpoint activity was partially rescued in the mad3-KEN2AAA and mad3-DCterm mutants, but not in mad3-KEN1AAA cells (Figure 2A ). Increasing the abundance of Mad2
(D) Schematic of the association between the ''core MCC'' and a second Slp1 Cdc20 molecule through motifs in the Mad3 C terminus, based on [4] .
(E) Anti-GFP immunoprecipitates from mitotic sfGFP-Slp1 cells with the additional genetic modifications indicated on top were analyzed by immunoblotting using anti-GFP, anti-Slp1, anti-Mad3, and anti-Mad2 antibodies. The tagged sfGFP-Slp1 Cdc20 was expressed from the endogenous promoter at the endogenous locus;
untagged Slp1 Cdc20 (Slp1 or Slp1-mr63) was expressed from the endogenous regulatory sequences at the exogenous leu1 locus.
(F) Checkpoint function of the indicated strains was analyzed as in (B). Wild-type or C-box mutant Slp1 Cdc20 was expressed under the endogenous regulatory sequences (Pslp1-slp1) from the exogenous leu1 locus, and Slp1 Cdc20 -mr63 was expressed at the endogenous locus either from the endogenous promoter (Pslp1) or from the rad21 + promoter, which reduces the concentration of Slp1 Cdc20 (Prad21; Figure S2A ) (wt, wild-type). Pooled data from at least two independent experiments are shown; n > 60 cells. See also Figure S1H .
(G) Anti-GFP immunoprecipitates from mitotic cells of the indicated strains were analyzed by immunoblotting (long and short exposure for the Slp1 blot).
and Mad3 slightly enhanced the effect ( Figure 2B ). The mitotic delay was dependent on core MCC formation, because Mad2-binding-deficient Slp1
Cdc20
-mr63 abolished the delay ( Figure 2B ). We obtained similar results when expressing slp1 cdc20 from the adh1 (alcohol dehydrogenase) promoter, which increases Slp1 Cdc20 concentration in interphase but lowers the concentration in mitosis ( Figures S2A and S2C ). This indicates that mitotic Slp1 concentrations are relevant for the phenotypic outcome.
To have yet better control over Slp1
Cdc20 concentration, we expressed the gene from the regulatable nmt41 promoter [27] ( Figure S2B ). When titrating down Slp1
, the mitotic arrest in response to microtubule depolymerization progressively improved in mad3-KEN2AAA and mad3-DCterm cells ( Figures  2C and 2D) . Together, this indicates that, at low Slp1 Cdc20 concentrations, the mitotic checkpoint can rely solely on core MCC formation ( Figure 2E ). Because KEN2 became at least partially unnecessary at low Slp1
Cdc20 concentrations, we asked whether some organisms may dispense with a second KEN box. In Drosophila species, the KEN2 motif seems to have become QEN (glutamine instead of lysine; Figures S1A and S1B) [7, 8] . Introducing this change into the S. pombe mad3 gene, however, did not impair checkpoint activity (Figures S1F and S1I ). This suggests that the Drosophila QEN motif may still mediate Cdc20 A binding. In C. elegans and related species, KEN2 seems entirely absent [7, 8, 10] . It would be interesting to know whether this coincides with a lower Cdc20 to Mad3 ratio.
An Intact Mad3 C Terminus and Apc15 Are Required for MCC Disassembly
We noticed that the amount of MCC was increased in Mad3-KEN2AAA or Mad3-DCterm mutants (e.g., Figures 1E and 1G) .
Because it is difficult to rationalize how these mutations could enhance MCC assembly, we hypothesized that disassembly is impaired. Indeed, the MCC (including Slp1 Cdc20 ) was abnormally present in interphase in these mutants (Figures 3 and S3A) . Because S. pombe Slp1 Cdc20 normally accumulates exclusively in mitosis [28] (Figure S2A ), this suggests that Slp1 Cdc20 is stabilized by incorporation into the partially defective MCC. Additional deletion of bub1 + largely abolished the presence of the MCC in interphase (Figures 3A and S3B) . Minor amounts could still be detected-presumably because Mad2 dimerization can initiate some MCC formation, even in the absence of Bub1 [9, 29] . The sequence of steps in MCC disassembly is not entirely clear [2] , but the APC/C subunit Apc15 plays a key role in human cells and budding yeast [30] [31] [32] . Consistently, we also detected the MCC in S. pombe apc15D interphase cells (Figure 3) . Hence, both Apc15 and the Mad3 C terminus are required for MCC disassembly in S. pombe.
An Intact Mad3 C Terminus and Apc15 Are Required for MCC Binding to APC/C In human cells and budding yeast, deletion of APC15 (budding yeast MND2) impairs checkpoint silencing and prolongs mitosis [30] [31] [32] . Surprisingly, deletion of apc15 + in S. pombe considerably impairs mitotic checkpoint activity ( Figure 4A ) [33] . Deletion of apc15 + and mutations of the Mad3 C terminus therefore have a similar phenotype: a mitotic checkpoint defect and a defect in MCC disassembly. Unlike in mad3-KEN2AAA cells, untagged Slp1
Cdc20 co-precipitates with sfGFP-Slp1
Cdc20 from apc15D cells ( Figure 4B ). Hence, in apc15D cells, the entire MCC assembles-yet cells are checkpoint defective. Strikingly, the interaction between the MCC and the APC/C is strongly diminished by apc15 deletion (also see [33] ): immunoprecipitation of Mad3-GFP from mitotic cells co-precipitated considerably less of the APC/C subunit Lid1/Apc4 than in wild-type cells ( Figure 4C ) and immunoprecipitation of the APC/C subunit Cut9/Apc6-GFP co-precipitated considerably less Mad2 and Mad3 ( Figure 4D ). We find a similar APC/C interaction defect in mad3-DCterm and to a lesser extent in mad3-KEN2AAA cells (Figures 4C and 4D ). This corroborates recent data on APC/C interaction defects of human Mad3/BubR1-ABBA1 and -ABBA2 mutants [7, 8] and therefore demonstrates that the sequences involved in the lariat capture of Cdc20 A are necessary for anchoring the core MCC to the APC/C across different eukaryotes. At least in S. pombe, however, Mad3-Cdc20 A interactions are not sufficient for anchoring, because we see assembly of a full MCC, largely unbound to the APC/ C, in apc15D cells (Figures 4B-4D) . The checkpoint defect of apc15D cells implies that assembly of this full MCC is not sufficient for Cdc20 inhibition. If the APC/C is not occupied by the MCC, additional Slp1 is free to interact with the APC/C (Figure 4D) and can initiate anaphase. To avoid this situation, the core MCC should have a preference to bind APC/C-Cdc20 over free Cdc20 [5] . This preference seems to be abolished in apc15D cells.
Sequestration of Cdc20 in the Full MCC Is Sufficient for Checkpoint Activity at Low Cdc20
Slp1 Concentration
Given the strong similarities in phenotype between deletion of apc15 + and mutations in the Mad3 C terminus, we tested whether Apc15 also becomes dispensable for mitotic checkpoint activity at low Cdc20 concentrations. Indeed, lowering the concentration of Cdc20 efficiently rescued checkpoint activity in apc15D cells ( Figure 4A ). The arrest was abolished by additionally deleting mad3 + ( Figure S3C ). The rescue was , whereas it most likely captures two Slp1
Cdc20 molecules in apc15D cells ( Figure 4B ). Hence, sequestration may be more efficient in apc15D cells ( Figure 4F ). Indeed, immunodepletion of Mad3-GFP from apc15D cells with reduced Slp1
Cdc20 concentration left hardly any Slp1 Cdc20 in the supernatant ( Figure 4E ). Furthermore, when we combined the apc15 deletion with the mad3-DCterm mutation in cells with intermediate Slp1 concentration, the efficient arrest of apc15D cells converted to the inefficient arrest of mad3-DCterm cells ( Figure 4A ). Combining all our data, we propose that inhibition of the APC/ C by the MCC comprises three elements: (1) sequestration of one Slp1
Cdc20 molecule in the core MCC, which can be sufficient at low Cdc20 concentrations (Figure 2 ), (2) inhibition of a second Slp1 Cdc20 molecule through the Mad3 C terminus, which is independent of Mad2 binding to this Slp1 Cdc20 ( Figures 1F and 1G ), and (3) occupancy of the APC/C with full MCC, which prevents excess Cdc20 from binding the APC/C (Figure 4 ). Only (3) is defective in apc15D cells, whereas (2) and (3) are defective in mad3D-Cterm cells ( Figure 4F ). All, (1), (2) , and (3), are defective in the mad3-KEN1AAA mutant-explaining the different extents of checkpoint impairment.
Why Does Lack of Apc15 Have Different Functional Consequences in Different Eukaryotes?
Whereas fission yeast cells lacking Apc15 have a checkpoint defect ( Figure 4A ) [33] , human and budding yeast cells lacking Apc15 or Mnd2, respectively, have a functional checkpoint [30] [31] [32] . This discrepancy can be explained by the loss of MCC-APC/C interaction in S. pombe apc15D cells ( Figures 4C  and 4D ), which has not been observed in human cells or budding yeast [4, 6, 30] . We speculate that, in these organisms, the loss of Apc15 is not detrimental for MCC-APC/C interaction because it is compensated for by Bub3 ( Figure 4G ). Bub3 is part of the MCC in human cells and budding yeast, but not S. pombe ( Figure S1 ). Circumstantial evidence has implicated Bub3 in MCC-APC/C binding [1, 19, 34] . Bub3 was not visible in electron microscopy structures of the human APC/C-MCC, though [4, 6] , suggesting a weak interaction.
Overall, our data reveal cellular effects of specific Mad3 mutants in S. pombe that strongly support recent biochemical and structural data from human cells. Our results differ on the functional role of Apc15. We speculate that Apc15 may contribute to MCC-APC/C binding across eukaryotes, but Apc15's role may be redundant in human cells and budding yeast. 
